As of Oct 02
| +0.40 / +3.27%|
The 1 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +18.58% increase from the last price of 12.65.
The current consensus among 1 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.